Noteworthy

Jul 20, 2018
New ideas and technological advances are two key methods leading to culture change in an organization. Graham Francis reports.
Jul 18, 2018
The Pfizer restructuring will be a case study in whether corporate restructuring & innovation can co-exist or whether M&A is the more viable answer, writes Edward Pratesi.
Jul 18, 2018
Alison Horstmeyer discusses how pharma executives can apply four attributes of curiosity to negotiate VUCA (volatile, uncertain, complex, and ambiguous) conditions and improve organizational outcomes.
Jul 13, 2018
Pharmaceutical Executive
Outlining a real-world case study in which building and operationalizing a patient- and customer-centric commercialization strategy drove a successful launch from a “standing start.”
Jul 13, 2018
Pharmaceutical Executive
The role of insurance and risk management in protecting middle-market distributors from the growing opioid multi-district litigation (MDL).
Jul 10, 2018
Pharmaceutical Executive
Pharm Exec convenes an expert panel to discuss new ways to navigate the many complexities of assessing business and risk in the life sciences.
Jul 09, 2018
Global pharma companies and Japan can create a win-win situation through a new pricing mechanism, writes Nobuko Kobayashi.
Jul 07, 2018
Pharmaceutical Executive
Streamlined clinical research, more guidance speed new cures to patients. Jill Wechsler reports.
Jul 07, 2018
Filip Conic outlines the market-access approaches and commercial strategies to unlock the growth potential in the Southeastern and Eastern European region.
Jun 30, 2018
Ron Wince explains how Pragmatic AI allows organizations to start with the basics, create immediate business value and ROI and then increase adoption as their comfort, capabilities and confidence increases.
native1_300x100
lorem ipsum